{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T02:05:40Z","timestamp":1725588340341},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","trasci.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.transci.2015.10.004","type":"journal-article","created":{"date-parts":[[2015,10,25]],"date-time":"2015-10-25T12:56:44Z","timestamp":1445777804000},"page":"271-275","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A strategical re-thinking on National Blood Donor Pool: Anti-HBc positivity related re-entry mechanisms"],"prefix":"10.1016","volume":"54","author":[{"given":"Soner","family":"Yilmaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aytekin","family":"Unlu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riza Aytac","family":"Cetinkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Yapar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail Yasar","family":"Avci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebahattin","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can Polat","family":"Eyigun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2015.10.004_bib0010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","article-title":"Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures","volume":"11","author":"Lavanchy","year":"2004","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.transci.2015.10.004_bib0020","doi-asserted-by":"crossref","first-page":"521","DOI":"10.5812\/jjm.4243","article-title":"HBsAg variants: common escape issues","volume":"5","author":"Dindoost","year":"2012","journal-title":"Jundishapur J Microbiol"},{"key":"10.1016\/j.transci.2015.10.004_bib0025","first-page":"134","article-title":"Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus?","volume":"138","author":"Niederhauser","year":"2008","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.transci.2015.10.004_bib0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1423-0410.2006.00818.x","article-title":"Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests","volume":"91","author":"Schmidt","year":"2006","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2015.10.004_bib0035","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1751-553X.2008.01092.x","article-title":"Sensitivity and specificity of anti-HBc screening assays\u2013which assay is best for blood donor screening?","volume":"31","author":"Hourfar","year":"2009","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.transci.2015.10.004_bib0040","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1046\/j.1537-2995.2002.00128.x","article-title":"NAT for HBV and anti-HBc testing increase blood safety","volume":"42","author":"Roth","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2015.10.004_bib0045","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1537-2995.2010.03031.x","article-title":"Evaluation of algorithms for the diagnostic assessment and the reentry of blood donors who tested reactive for antibodies against hepatitis B core antigen","volume":"51","author":"Juhl","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2015.10.004_bib0050","first-page":"33","article-title":"Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT","volume":"36","author":"Liu","year":"2006","journal-title":"J ClinVirol"},{"key":"10.1016\/j.transci.2015.10.004_bib0055","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00705-009-0559-6","article-title":"The underlying mechanisms for the \u2018anti-HBc alone\u201d serological profile","volume":"155","author":"Pond\u00e9","year":"2010","journal-title":"Arch Virol"},{"key":"10.1016\/j.transci.2015.10.004_bib0060","first-page":"35","article-title":"G\u00f6n\u00fcll\u00fc ve g\u00f6n\u00fcll\u00fc olmayan kan don\u00f6rlerinde HBV, HCV, HIV ve sifiliz tarama test sonu\u00e7lar\u0131n\u0131n de\u011ferlendirilmesi","volume":"36","author":"G\u00fcl","year":"2006","journal-title":"T\u00fcrk Mikrobiyol Cem Derg"},{"key":"10.1016\/j.transci.2015.10.004_bib0065","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ejim.2007.07.001","article-title":"Determination of hepatitis B virus DNA incidence, viral load, and mutations in blood donors with HBsAg and anti-HBs-negative serology and antibodies to hepatitis B core antigen","volume":"18","author":"Findik","year":"2007","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.transci.2015.10.004_bib0070","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1046\/j.1537-2995.2003.00512.x","article-title":"Evaluation of serologic screening of blood donors in India reveals a lack of correlation between anti-HBc titer and PCR-amplified HBV DNA","volume":"43","author":"Chaudhuri","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2015.10.004_bib0075","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1537-2995.2004.04055.x","article-title":"Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy","volume":"44","author":"Kuhns","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2015.10.004_bib0080","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.transci.2010.09.013","article-title":"Can the nucleic acid amplification test (NAT) be an alternative to the serologic tests? A prospective study, the results of 18,200 blood donors from the Turkish Red Crescent","volume":"43","author":"Kosan","year":"2010","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2015.10.004_bib0085","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1537-2995.2007.01066.x","article-title":"Anti-hepatitis B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice","volume":"47","author":"Bhatti","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2015.10.004_bib0090","first-page":"312","article-title":"Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: implications for blood transfusion","volume":"132","author":"Asim","year":"2010","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.transci.2015.10.004_bib0095","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/1096-9071(200012)62:4<450::AID-JMV9>3.0.CO;2-Y","article-title":"Serological pattern \u201canti-HBc alone\u201d report on a workshop","volume":"62","author":"Grob","year":"2000","journal-title":"J Med Virol"},{"key":"10.1016\/j.transci.2015.10.004_bib0100","first-page":"17","article-title":"Kan don\u00f6rlerinde izole hepatit B virus core antikorlar\u0131n\u0131n ara\u015ft\u0131r\u0131lmas\u0131","volume":"5","author":"Kaya","year":"2009","journal-title":"Nobel Med"},{"key":"10.1016\/j.transci.2015.10.004_bib0105","first-page":"243","article-title":"Investigation of the presence of HBV-DNA in isolated anti-HBc positive cases and their importance in blood banking","volume":"43","author":"Bal","year":"2009","journal-title":"Mikrobiyol Bul"},{"key":"10.1016\/j.transci.2015.10.004_bib0110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.transci.2010.09.012","article-title":"Are isolated anti-HBc blood donors in high risk group? The detection of HBV DNA in isolated anti-HBc cases with nucleic acid amplification test (NAT) based on transcription-mediated amplification (TMA) and HBV discrimination","volume":"43","author":"Altunay","year":"2010","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2015.10.004_bib0115","first-page":"535","article-title":"High rate of hepatitis B virus DNA positivity in anti-HBc only-positive patients","volume":"42","author":"Yildirim","year":"2008","journal-title":"Mikrobiyol Bul"},{"key":"10.1016\/j.transci.2015.10.004_bib0120","first-page":"92","article-title":"HBsAg ve anti-HBs negatif, anti-HBc pozitif olgular\u0131n \u00e7e\u015fitli y\u00f6nlerden incelenmesi","volume":"2","author":"Mert","year":"1996","journal-title":"Viral Hepatit Derg"},{"key":"10.1016\/j.transci.2015.10.004_bib0125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/jmv.1890420210","article-title":"Presence of hepatitis B and C viral genomes in US blood donors as detected by polymerase chain reaction amplification","volume":"42","author":"Liang","year":"1994","journal-title":"J Med Virol"},{"key":"10.1016\/j.transci.2015.10.004_bib0130","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.transci.2012.07.009","article-title":"The detection of occult HBV infection in patients with HBsAg negative pattern by real-time PCR method","volume":"47","author":"Izmirli","year":"2012","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2015.10.004_bib0135","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1046\/j.1537-2995.1993.33393174446.x","volume":"33","author":"Douglas","year":"1993","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2015.10.004_bib0140","unstructured":"Guide to the Preparation, Use and Quality Assurance of Blood Components. Recommendation No.R (95) 15. European Directorate for the Quality of Medicines & HealthCare."},{"key":"10.1016\/j.transci.2015.10.004_bib0145","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1046\/j.1537-2995.2001.41091107.x","article-title":"Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assay","volume":"41","author":"Sato","year":"2001","journal-title":"Transfusion"},{"issue":"11","key":"10.1016\/j.transci.2015.10.004_bib0155","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1111\/j.1537-2995.2008.01844.x","article-title":"Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen","volume":"48","author":"Katz","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2015.10.004_bib0160","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1046\/j.1537-2995.2003.00391.x","article-title":"Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening","volume":"43","author":"Kleinman","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2015.10.004_bib0165","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1046\/j.1365-2141.1999.01665.x","article-title":"Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion","volume":"107","author":"Allain","year":"1999","journal-title":"Br J Haematol"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050215001652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050215001652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T04:55:41Z","timestamp":1537246541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050215001652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1473050215001652"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2015.10.004","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A strategical re-thinking on National Blood Donor Pool: Anti-HBc positivity related re-entry mechanisms","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2015.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}